Voloridge Investment Management, LLC Igm Biosciences, Inc. Transaction History

Voloridge Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$15.42 - $27.01 $967,188 - $1.69 Million	-62,723 Reduced 61.71%	38,914 $885,000
Q2 2022 Aug 15, 2022	SELL	$13.27 - $25.5 $807,506 - $1.55 Million	-60,852 Reduced 37.45%	101,637 $1.83 Million
Q1 2022 May 16, 2022	BUY	$13.42 - $29.73 $872,501 - $1.93 Million	65,015 Added 66.7%	162,489 $4.34 Million
Q4 2021 Feb 14, 2022	BUY	$27.59 - $66.39 $2.69 Million - $6.47 Million	97,474 New	97,474 $2.86 Million
Q1 2021 May 17, 2021	SELL	$71.56 - $121.23 $645,757 - $1.09 Million	-9,024 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$47.41 - $115.03 $990,774 - $2.4 Million	-20,898 Reduced 69.84%	9,024 $797,000
Q3 2020 Nov 16, 2020	BUY	$43.0 - $84.01 $1.29 Million - $2.51 Million	29,922 New	29,922 $2.21 Million

20.7M

68K

52.2K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $214M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.